Drug Pipeline
An overview of recently approved therapies, anticipated approvals in the year to come, and strategies to help manage the pipeline More
Feature
“Breakthrough Therapy”
7 result(s)
Drug Pipeline
Peanut allergy is the most common of childhood food allergies — and getting more common. Research presented at the annual meeting of the American College of Allergy, Asthma and... More
Feature
Cost Management
Epidiolex, the latest cannabis-based drug to be approved by the FDA to treat certain seizure disorders, is a highly potent form of cannabidiol. Given the narrow indication and... More
Feature
Specialty
Treatment options for hemophilia continue to expand, which is good news for patients. Recently approved therapy options offer better outcomes but need careful management. More
Briefing
Drug Pipeline
When the FDA approves a “supplemental indication” for a drug already on the market — permitting it to be used for new conditions or stages of a disease, or additional patient... More
Briefing
Cost Management
High Drug Prices: Who is Responsible?
With prescription drug prices very much in the news, the question often asked is: Who is responsible for high drug prices? Pharmaceutical manufacturers — and no one else — set... More
Commentary
Specialty
Gene therapies bring hope for patients with conditions with few or no treatments, but also other considerations including safety and cost. More
Feature